Author:
Farooqui Anam,Alhazmi Alaa,Haque Shafiul,Tamkeen Naaila,Mehmankhah Mahboubeh,Tazyeen Safia,Ali Sher,Ishrat Romana
Abstract
AbstractThe information on the genotype–phenotype relationship in Turner Syndrome (TS) is inadequate because very few specific candidate genes are linked to its clinical features. We used the microarray data of TS to identify the key regulatory genes implicated with TS through a network approach. The causative factors of two common co-morbidities, Type 2 Diabetes Mellitus (T2DM) and Recurrent Miscarriages (RM), in the Turner population, are expected to be different from that of the general population. Through microarray analysis, we identified nine signature genes of T2DM and three signature genes of RM in TS. The power-law distribution analysis showed that the TS network carries scale-free hierarchical fractal attributes. Through local-community-paradigm (LCP) estimation we find that a strong LCP is also maintained which means that networks are dynamic and heterogeneous. We identified nine key regulators which serve as the backbone of the TS network. Furthermore, we recognized eight interologs functional in seven different organisms from lower to higher levels. Overall, these results offer few key regulators and essential genes that we envisage have potential as therapeutic targets for the TS in the future and the animal models studied here may prove useful in the validation of such targets.
Funder
Indian Council of Medical Research
Jazan University
Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. Gravholt, C. H. et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur. J. Endocrinol. 177, G1–G70 (2017).
2. Karyotype-phenotype analyses across the lifespan. Cameron- Pimblett, A., La Rosa, C., King, T. F. J., Davies, M. C. & Conway, G. S. The Turner syndrome life course project. Clin. Endocrinol. (Oxf.) 87, 532–538 (2017).
3. Urbach, A. & Benvenisty, N. Studying Early Lethality of 45,XO (Turner’s Syndrome) Embryos Using Human Embryonic Stem Cells. PLoS ONE 4, e4175 (2009).
4. Sun, L. et al. Glucose Metabolism in Turner Syndrome. Front. Endocrinol. 10, 49 (2019).
5. Muntaj, S., Feroze A Ganaie, Purva, S. V., S Radhika & Tilak, P. Karyotypic variables in turner syndrome: A case series. Int. J. Sci. Study 3, 171–175 (2015).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献